Acquisitions and Other Transactions (Meda) (Narrative) (Details) SEK / shares in Units, € in Millions, shares in Millions, $ in Millions, SEK in Billions				1 Months Ended	3 Months Ended	5 Months Ended	12 Months Ended
		Aug. 05, 2016 EUR (€) shares	Aug. 05, 2016 USD ($) shares	Nov. 30, 2016 USD ($) shares	Jun. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Feb. 21, 2017	Nov. 01, 2016 SEK / shares	Aug. 05, 2016 SEK / shares	Aug. 05, 2016 USD ($)		Jul. 29, 2016 shares	Feb. 10, 2016 SEK	Feb. 10, 2016 USD ($)
Business Acquisition [Line Items]
Stock Issued During Period, Value, Acquisitions							$ 1,281.7	$ 6,305.8	$ 0.0
Compulsory acquisition proceeding liability													$ 431.0
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net							(104.5)	(29.5)	(78.3)
Goodwill						$ 9,231.9	9,231.9	5,380.1	4,049.3
Acquisitions (1)	[1]						4,002.2	1,658.2
Other Payments to Acquire Businesses			$ 308.0				308.0	0.0	0.0
Total revenues							11,076.9	9,429.3	7,719.6
Net earnings							480.0	847.7	$ 933.1
Meda AB
Business Acquisition [Line Items]
Net assets acquired						6,921.1	6,921.1						6,921.1	[2]		SEK 83.6	$ 9,900.0
Foreign Currency Exchange Rate, Translation																8.4158	8.4158
Business acquisition, number of shares tendered | shares				19.0											343.0
Cash paid for shares tendered				$ 330.3
Business Acquisition, Percentage of Voting Interests Acquired															94.00%
Business Acquisition, Share Price | SEK / shares											SEK 161.31
Acquisition purchase price			$ 5,300.0
Consideration transferred, shares | shares		26.4	26.4
Compulsory acquisition proceeding liability						70.2	70.2	$ 0.0
Business Combination, Acquisition Related Costs							182.0
Business combination, fair value inventory step-up													107.0
Identified intangible assets						8,060.7	8,060.7						8,060.7	[2]
Goodwill						3,676.9	3,676.9						$ 3,677.6	[2]
Acquisitions (1)							3,680.0
Amount of goodwill expected to be tax deductible						0.0	0.0
Other Payments to Acquire Businesses | €		€ 275
Total revenues						833.9
Net earnings						$ 208.7
Meda AB | Other expense
Business Acquisition [Line Items]
Foreign Currency Transaction Gain (Loss), before Tax							30.5
Twenty percent of number of shares tendered | Meda AB
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired													20.00%
Business combination, share conversion ratio													0.386
Eighty percent of number of shares tendered | Meda AB
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired													80.00%
Maximum | Eighty percent of number of shares tendered | Meda AB
Business Acquisition [Line Items]
Business Acquisition, Share Price | SEK / shares												SEK 165
Swedish krona denominated contracts | Other expense
Business Acquisition [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net							128.6
Bridge Loan
Business Acquisition [Line Items]
Debt Related Commitment Fees and Debt Issuance Costs					$ 30.2		45.2
Product rights and licenses | Meda AB
Business Acquisition [Line Items]
Identified intangible assets													$ 8,060.0
Acquired intangible assets, weighted average useful life, in years		20 years	20 years
Subsequent Event | Meda AB
Business Acquisition [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage										100.00%
Business Acquisition, Percentage of Voting Interests Acquired										1.00%
Mylan N.V
Business Acquisition [Line Items]
Stock Issued During Period, Value, Acquisitions							$ 1,300.0

[1] In 2015, includes goodwill related to the acquisition of the EPD Business and Jai Pharma Limited totaling approximately $1.34 billion and $317.2 million, respectively. In 2016, includes measurement period adjustments related to the acquisition of Jai Pharma Limited and the recognition of goodwill related to the acquisitions of Meda and the Topicals Business totaling approximately $6.7 million, $3.68 billion and $318.6 million, respectively.

[2] As previously reported in the Company’s Quarterly Report on Form 10-Q for the nine months ended September 30, 2016.